Perfluoroperhydrophenanthrene

Perfluoroperhydrophenanthrene and pregnancy

Not Recommended

• Absorbed into the body
• Fetal development
• Hormone disruptor

Perfluoroperhydrophenanthrene belongs to the family of perfluorinated compounds (PFCs), synthetic chemicals that contain multiple fluorine atoms. It's used as a solvent in cosmetics for its unique properties, including oxygen-carrying capacity and chemical stability. According to research published in Environmental Health Perspectives, various perfluorinated compounds have been detected in umbilical cord blood, demonstrating placental transfer. Studies on related PFCs suggest potential associations with reduced birth weight, developmental delays, and endocrine disruption. While this specific compound hasn't been extensively studied during pregnancy, the persistence and bioaccumulative nature of PFCs raises significant concerns. Most dermatologists recommend avoiding perfluorinated compounds during pregnancy due to their long half-life in the body and uncertainty about developmental effects. The EPA and ECHA have begun regulating certain PFCs due to health and environmental concerns. Given the limited safety data specific to pregnancy and the known risks of related fluorinated compounds, many healthcare providers advise pregnant women to avoid products containing perfluorinated ingredients as a precautionary measure.

Perfluoroperhydrophenanthrene and breastfeeding

Not Recommended

• Passes into breast milk
• Infant exposure

Perfluorinated compounds are lipophilic (fat-soluble) substances that can accumulate in fatty tissues. Research has consistently shown that various PFCs transfer into breast milk and can be detected in breastfed infants. According to studies in Environmental Science & Technology, perfluorinated compounds have been measured in breast milk samples worldwide. The fat-soluble nature of these chemicals means they can accumulate and transfer to infants through breastfeeding. While specific data on perfluoroperhydrophenanthrene in breast milk is limited, the chemical class shows consistent patterns of bioaccumulation and milk transfer. Given the persistence of PFCs in the body (elimination half-lives can be years), potential infant exposure through breast milk, and limited safety data, most toxicologists and pediatricians recommend avoiding cosmetic products containing perfluorinated compounds during breastfeeding. The AAP notes that minimizing maternal exposure to persistent organic pollutants benefits infant health.

Perfluoroperhydrophenanthrene and postpartum

Caution Advised

• Absorbed into the body
• Environmental pollutant

For postpartum women who are not breastfeeding, the primary concern with perfluoroperhydrophenanthrene is its persistence in the body and potential for bioaccumulation over time. These compounds have extremely long elimination half-lives. While the immediate risks are lower without concerns about milk transfer, the long-term accumulation of perfluorinated compounds in body tissues remains a consideration. If planning future pregnancies, avoiding PFCs allows time for any accumulated compounds to be eliminated. Many women prefer to minimize exposure to persistent chemicals during the postpartum recovery period.

Perfluoroperhydrophenanthrene and trying to conceive

Not Recommended

• Fertility effects
• Hormone disruptor
• Builds up in tissue

When trying to conceive, minimizing exposure to persistent bioaccumulative compounds like perfluoroperhydrophenanthrene is advisable. These chemicals can take months to years to clear from the body once accumulated. Research published in Human Reproduction has found associations between elevated levels of certain perfluorinated compounds and reduced fertility, longer time to pregnancy, and increased risk of pregnancy loss. While specific data on this compound is limited, the long half-life of PFCs means that exposure during the preconception period can result in elevated levels during early pregnancy. Many fertility specialists recommend avoiding PFCs for at least 3-6 months before attempting conception to allow for clearance.

Perfluoroperhydrophenanthrene and PCOS

Caution Advised

• Hormone disruptor
• Can inflame skin

Perfluoroperhydrophenanthrene is a fluorinated solvent used in cosmetics. Women with PCOS often have underlying hormonal sensitivity and metabolic concerns that make exposure to potential endocrine disruptors particularly relevant. Research on various perfluorinated compounds has suggested potential effects on hormonal pathways and metabolic function. A study in the Journal of Clinical Endocrinology & Metabolism found associations between certain PFCs and altered reproductive hormone levels. While this specific compound hasn't been studied in PCOS populations, the broader concerns about PFCs and endocrine function are relevant for women managing hormonal conditions. Given the hormonal sensitivity in PCOS and the potential for PFCs to interfere with metabolic and reproductive function, many endocrinologists recommend minimizing exposure to perfluorinated compounds. While topical exposure is lower than dietary sources, avoiding these ingredients aligns with an overall approach to reducing endocrine disruptor exposure.

Perfluoroperhydrophenanthrene and general use

Caution Advised

• Environmental pollutant
• Absorbed into the body
• Endocrine disruptor

Perfluoroperhydrophenanthrene is a synthetic fluorinated compound used as a solvent in cosmetic formulations. It belongs to the perfluorinated chemical (PFC) family, which are known for their environmental persistence and bioaccumulative properties. The primary concerns with perfluorinated compounds for the general public relate to their extreme persistence in both the environment and human body. These chemicals can have elimination half-lives of several years, meaning they accumulate over time. While dermal absorption from cosmetics is likely lower than dietary exposure, chronic use contributes to body burden. Some perfluorinated compounds have been associated with immune effects, liver changes, and potential endocrine disruption in animal and epidemiological studies. European regulatory bodies including ECHA have begun restricting certain PFCs in consumer products due to environmental and health concerns. While this specific compound may not yet be regulated, the trend is toward limiting PFC use. Many consumers and environmental health advocates choose to avoid perfluorinated ingredients when alternatives are available.

Everything else flagged for the same profiles

• Flagged in pregnancy
• Flagged in breastfeeding
• Flagged in trying to conceive
• Flagged in postpartum
• Flagged in PCOS

Related ingredients

Ingredients suggested in place of Perfluoroperhydrophenanthrene, each one with its own page here.

• Glycerin
• Squalane

Ingredients that raise the same concerns.

• TriclosanEnvironmental pollutant, Can inflame skin, Endocrine disruptor
• PerfluorodecalinEnvironmental pollutant, Endocrine disruptor, Builds up in tissue
• Perfluorooctyl TriethoxysilaneEnvironmental pollutant, Endocrine disruptor, Builds up in tissue
• PerfluorohexaneEnvironmental pollutant, Endocrine disruptor, Builds up in tissue
• Polyperfluoromethylisopropyl EtherEnvironmental pollutant, Endocrine disruptor, Builds up in tissue
• Polyperfluoroethoxymethoxy Difluoroethyl PEG PhosphateEnvironmental pollutant, Endocrine disruptor, Builds up in tissue

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.